Tag: cancer

The United States Food and Drug Administration (FDA) closed the month of September with a series of landmark decisions that significantly expand the therapeutic landscape for endocrine-related disorders. These regulatory actions include the first-ever approval for a rare genetic condition known as MCT8 deficiency, the authorization of a once-weekly basal insulin for type 2 diabetes,…

On September 11, the Endocrine Society formally submitted a comprehensive set of comments to the Centers for Medicare and Medicaid Services (CMS) regarding the proposed rule for the Calendar Year 2027 Medicare Physician Fee Schedule (MPFS). This annual regulatory update serves as the primary mechanism for adjusting payment policies and reimbursement rates for Part B…

In the rapidly evolving landscape of modern medicine, the electronic health record (EHR) has transitioned from a mere digital repository of patient charts into a sophisticated clinical engine capable of driving complex decision-making. For endocrinologists, whose work involves the longitudinal management of chronic conditions such as diabetes, thyroid disorders, and hormonal imbalances, the requirements for…

The landscape of endocrine oncology is undergoing a period of rapid transformation, driven by the dual imperatives of precision medicine and the democratization of complex clinical protocols. As the global medical community grapples with the rising burden of rare and metastatic cancers, the latest clinical findings and educational initiatives highlighted by the Endocrine Society emphasize…

A significant longitudinal study conducted by researchers at the Juntendo University Graduate School of Medicine in Tokyo has identified a compelling link between extended sleep duration and the deterioration of kidney function in patients diagnosed with type 2 diabetes. The research, published in the Journal of the Endocrine Society, suggests that individuals with diabetes who…

On September 29, a high-level delegation of medical professionals, policy experts, and patient advocates descended upon Capitol Hill to deliver a unified message to the United States Congress: the historical underfunding and systemic neglect of women’s health research must end. Led by the Endocrine Society in collaboration with the Society for Women’s Health Research (SWHR),…

The landscape of high-stakes biomedical research is often defined by its breakthroughs, yet the underlying reality for many investigators is a persistent cycle of trial, error, and professional setbacks. At the ENDO 2026 conference in Chicago, a premier international gathering for endocrine research and clinical practice, this often-ignored aspect of the scientific career took center…

On September 17, members of the Endocrine Society joined a broad coalition of advocates, researchers, and healthcare professionals in Washington, D.C., for the 13th annual Rally for Medical Research. This high-profile day of action brought together hundreds of stakeholders from across the United States to engage directly with members of Congress, urging them to prioritize…

The Endocrine Society has officially named Lisa B. Nachtigall, MD, as the 2026 recipient of the Vigersky Outstanding Clinical Practitioner Award, a prestigious Laureate honor recognizing physicians who demonstrate exceptional commitment to clinical endocrinology. As the Medical Director of the Mass General Brigham Pituitary Center and an Associate Professor of Medicine at Harvard Medical School,…

Neuroendocrine neoplasms (NENs) represent a complex and heterogeneous group of tumors that can manifest in virtually any organ system, posing a significant challenge for oncologists and researchers alike. Because these tumors originate from diverse anatomical sites—ranging from the gastrointestinal tract and lungs to the pancreas and adrenal glands—they are often described by medical professionals as…